President
David Gallinson, DO

David Gallinson, DO, specializes in hematology/oncology and received his training at St. Vincent's Comprehensive Cancer Center in New York City. In addition to seeing a broad range of disease states, Dr. Gallinson has special interests including gastrointestinal cancers, blood disorders, lymphoma and genitourinary cancers.

He is President of the Oncology Society of New Jersey, and is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Dr.Gallinson's awards include the Lester Granet Humanitarian Award, the Golden Apple Award in Teaching and Resident of the Year, Morristown Memorial Hospital.

Vice President
Charles Farber, PhD, MD

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for Adolescent and Young Adult, has an academic appointment at Translational Genomics, and serves as Vice President of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory.